[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-events-search:[\"\",\"\",\"JNL\",\"1990-01-01\",\"2026-11-17\",1]":3,"fda-latest-sync-dates":26},{"events":4,"total":25},[5],{"mdr_report_key":6,"report_number":7,"event_type":8,"date_received":9,"date_of_event":10,"report_source_code":11,"adverse_event_flag":12,"product_problem_flag":12,"product_problems":13,"brand_name":15,"generic_name":16,"product_code":17,"manufacturer_name":18,"model_number":19,"patient_outcomes":20,"remedial_action":22,"created_at":24,"updated_at":24},"22787575","2122870-2025-00090","Injury","2025-08-12","2025-07-14","Manufacturer report","Y",[14,14],"High Test Results","ACCESS THYROGLOBULIN","IMMUNOCHEMICAL, THYROGLOBULIN AUTOANTIBODY","JNL","BECKMAN COULTER, INC.","",[21],"Other",[23],"Recall","2026-07-15T12:52:49.063594+00:00",1,{"510k":27,"classification":28,"enforcement":29,"event":30,"event_backfill":31,"pma":32,"warning_letter":33},"2026-11-16T02:00:55.89+00:00","2026-11-16T02:00:41.999+00:00","2026-11-16T02:00:49.415+00:00","2026-11-17T04:00:34.414+00:00","2026-09-07T05:17:28.839+00:00","2026-11-16T02:01:03.155+00:00","2026-11-17T01:02:55.859+00:00"]